Patent Assignment
Reel/Frame 059935/0837
Assignment of Assignor's Interest
Recorded: 2022-05-17
Pages: 5
Assignee
4-ANTIBODY AG
HOCHBERGERSTRASSE 60C, BASEL, CH-4057, SWITZERLAND
Covered Property
(1)
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Assignment of Assignor's Interest
May 17, 2022
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 059935/0855 →
Assignment of Assignor's Interest
May 17, 2022
From: RITTER, GERD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 059935/0884 →
Assignment of Assignor's Interest
May 17, 2022
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 059935/0825 →
Assignment of Assignor's Interest
May 17, 2022
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 059935/0889 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Security Interest
Mar 31, 2025
From: AGENUS, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070680/0634 →